• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[巴氏试验在宫颈细胞学筛查中的价值]

[Value of the Pap-test in the cervical cytological screening].

作者信息

Giannone R, Piacezzi C, Poli M, Bernorio R

机构信息

Divisione di Ostetricia e Ginecologia, Presidio Ospedaliero, Casorate Primo, Pavia.

出版信息

Minerva Ginecol. 1992 Apr;44(4):155-9.

PMID:1584446
Abstract

Fourteen thousand three hundred fifty six cervical smears were performed in the Obstetric and gynaecologic Department of Casorate Primo Hospital (USSL no. 77) and Oncologic Center of Milan (USSL no. 75/II) between 1-1-1987 and 30-6-1991. The incidence and mortality of uterine cervix neoplasm are discussed and the uterine cervix neoplasm are discussed and the analysis of data shows a reduction of this cancer in all countries. In italy it is estimated that the incidence is of 20.88 per 1000,000 women of all ages.

摘要

1987年1月1日至1991年6月30日期间,卡索拉特·普里莫医院(地方卫生机构编号77)妇产科和米兰肿瘤中心(地方卫生机构编号75/II)共进行了14356次宫颈涂片检查。本文讨论了子宫颈肿瘤的发病率和死亡率,数据分析表明所有国家的这种癌症发病率都有所下降。在意大利,估计所有年龄段女性的发病率为每1000000人中有20.88例。

相似文献

1
[Value of the Pap-test in the cervical cytological screening].[巴氏试验在宫颈细胞学筛查中的价值]
Minerva Ginecol. 1992 Apr;44(4):155-9.
2
[The Pap test revisited].[重新审视巴氏试验]
Minerva Ginecol. 1991 Mar;43(3):71-85.
3
[Cytological history of 101 patients with invasive cancer of the uterine cervix].
Minerva Ginecol. 1991 Jun;43(6):273-7.
4
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.筛查可预防的宫颈癌风险:来自瑞典全国性审计的证据。
J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29.
5
[Incidence and mortality of uterine cervix cancer in Norway. When do we get organized nation-wide cytologic screening in Norway?].
Tidsskr Nor Laegeforen. 1990 May 10;110(12):1557-9.
6
Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.根据我们32年基于医院的常规细胞学筛查经验,评估41至50岁单次终身巴氏涂片检查作为发展中国家宫颈癌控制策略的可行性。
Diagn Cytopathol. 2004 Dec;31(6):376-9. doi: 10.1002/dc.20105.
7
Evaluation of cervical cancer screening program at a rural community of South Africa.南非一个农村社区宫颈癌筛查项目的评估
East Afr J Public Health. 2008 Aug;5(2):111-6.
8
Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.意大利261例浸润性宫颈癌患者的哨点巴氏涂片检查
Vaccine. 2009 May 29;27 Suppl 1:A34-8. doi: 10.1016/j.vaccine.2008.11.080.
9
The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy.细胞学筛查对腺癌也有效:意大利特伦托一项基于人群的病例对照研究。
Eur J Cancer Prev. 2007 Dec;16(6):564-7. doi: 10.1097/CEJ.0b013e3280145c14.
10
Cervical cancer screening in a rural population of Zimbabwe.津巴布韦农村人口的宫颈癌筛查
Cent Afr J Med. 1997 Sep;43(9):246-51.